New investment team to back early- to growth-stage companies

New investment team to back early- to growth-stage companies

 

JPMorgan Chase & Co. has launched a healthcare venture-capital practice, entering the market at a time when innovation in the life sciences remains high but investment has pulled back from last year’s record pace.

The largest U.S. bank by assets has created a venture team targeting the life sciences through J.P. Morgan Private Capital, a growth-equity and private-credit investment group within J.P. Morgan Asset Management.

Fuente: The Wall Street Journal

Previous
Previous

Calling all interdisciplinary graduate students and professional mentors!

Next
Next

We Will See the Return of Capital Investment on a Massive Scale